3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients

Author(s):
Verly, I.R.N.; Kuilenburg, A.B.P. van; Abeling, N.G.G.M.; Goorden, S.M.I.; Fiocco, M.; Vaz, F.M.; Noesel, M.M. van; Zwaan, C.M.; Kaspers, G.J.L.; Merks, J.H.M.; Caron, H.N.; Tytgat, G.A.M.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-02-28
Language
English
Is part of
European Journal of Cancer (2018), Vol. 90, p. 102-110
hdl
1887/95834
doi
10.1016/j.ejca.2017.11.025